Inbiogen인바이오젠
101140 · KOSPI · ₩101140 · 인바이오젠
- Market cap
- ₩46B
- Enterprise value
- ₩44B
- P/E
- —
- P/B
- 0.3×
- Dividend yield
- 0.0%
- ROE
- −2.8%
- Net margin
- −78.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−67.8% from the high
₩4,255Today: ₩4,535 – ₩4,760₩14,290
Returns
- 1W−6.5%
- 1M+2.6%
- 3M−5.1%
- 6M−47.6%
- YTD−56.1%
- 1Y−64.7%
- Volume today
- 348
- 0.1× the 20-day average
- Traded today
- ₩1.6M
- Listed shares
- 10,044,216
- EPS (12 months)
- −₩400
- Earnings yield −8.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat-2% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Inbiogen stock overview
Inbiogen (인바이오젠, KRX: 101140) is listed on KOSPI, in the Retail & Trade sector. The company operates a kiosk distribution business and a food and beverage (F&B) business. Its shares closed at ₩4,605 on Oct 29, 2026, down 3.56% on the day, giving it a market value of ₩46B.
Key facts
- Market cap
- ₩46B
- Sector
- Retail & Trade
- Latest price change
- −3.56%
- As of
- Oct 29, 2026
- Main business
- The company operates a kiosk distribution business and a food and beverage (F&B) business.
Quick answers about Inbiogen
- What does Inbiogen do?
- The company operates a kiosk distribution business and a food and beverage (F&B) business. 6% of total sales, sells unmanned payment kiosks to customers such as restaurants, coin karaoke rooms, and franchise stores, with EnjoySoft cited as a major customer. 4% of sales.
- What is the market cap of Inbiogen?
- The market capitalisation of Inbiogen was ₩46B at the close on Oct 29, 2026.
- Who are the largest shareholders of Inbiogen?
- According to the latest official filings, the largest reported holders are Buckets Studio (78.90%, as of Aug 20, 2026); National Pension Service (0.01%, as of Dec 31, 2025).
- When is the next earnings report from Inbiogen?
- Korean companies rarely announce results dates in advance. Based on when Inbiogen filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Inbiogen?
- Yes. The National Pension Service held 0.01% of Inbiogen shares as of Dec 31, 2025.
Company profile
The company operates a kiosk distribution business and a food and beverage (F&B) business. Its kiosk business, which accounts for about 89.6% of total sales, sells unmanned payment kiosks to customers such as restaurants, coin karaoke rooms, and franchise stores, with EnjoySoft cited as a major customer. Its F&B business sells food and beverages to general consumers, targeting MZ-generation customers, and makes up about 10.4% of sales.
Written by AI from the company's latest annual report.
- Korean name
- 인바이오젠
- Sector
- Retail & Trade
- Themes
- Biotech (new drugs)
- CEO
- 강지연
- Founded
- Mar 2008
- Listed
- Apr 2008
- Listed shares
- 10,044,216
- Fiscal year ends
- Month 12
- Website
- www.inbiogen.co.kr
Similar companies
- Samsung C&T028260 · ₩52T₩323,500−0.31%
- POSCO International047050 · ₩8.7T₩49,250−1.01%
- ISC095340 · ₩3.5T₩166,200+0.18%
- Youngone111770 · ₩3T₩68,500+1.18%
- Dong SUH Companies026960 · ₩2.8T₩27,800+1.46%
- Shinsegae004170 · ₩2.3T₩248,000−3.69%
- SK Gas018670 · ₩2.3T₩252,500+0.80%
- Lotte Shopping023530 · ₩2.3T₩82,300−1.67%
Recent filings
See all- 5%+ holding reportAug 20, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Results of Extraordinary Shareholders' MeetingJun 30, 2026
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent DirectorsJun 30, 2026
- Amended: Shareholders' meeting calledJun 15, 2026
Titles in Korean until English translations are added.
Also known as: Inbiogen / 인바이오젠 / 101140 / KRX:101140
Source: KRX statistical information